Biohaven (BHVN) Retained Earnings (2022 - 2026)
Biohaven's (BHVN) quarterly Retained Earnings came in at -$2.2 billion in Q1 2026, down 3034439.73% year-on-year from N/an in Q1 2025, and down 6.26% quarter-over-quarter from -$2.1 billion in Q4 2025.
Biohaven (BHVN) Retained Earnings (2022 - 2026) Analysis & Trends
Biohaven has disclosed Retained Earnings across 5 years of filings, most recently posting -$2.2 billion for Q1 2026.
- Retained Earnings for Q1 2026 came in at -$2.2 billion, down 3034439.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.2 billion (down 3034439.73% YoY), and the FY2025 annual result was -$2.1 billion, down 54.9% from the prior year.
- Retained Earnings came in at -$2.2 billion for Q1 2026 at Biohaven, down from -$2.1 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $284000.0 in Q4 2022 to a low of -$2.2 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$80.9 million (2023), against an average of -$695.0 million.
- Across the five-year window, Retained Earnings plunged 4992935.0% in 2024 and jumped 168.87% in 2025, its largest moves.
- Biohaven's Retained Earnings stood at $284000.0 in 2022, then slumped by 122.89% to -$65000.0 in 2023, then tumbled by 2070229.23% to -$1.3 billion in 2024, then tumbled by 54.9% to -$2.1 billion in 2025, then dropped by 6.26% to -$2.2 billion in 2026.
- The last three Retained Earnings figures came in at -$2.2 billion (Q1 2026), -$2.1 billion (Q4 2025), and $36000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | -2.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.22 Bn |
| Dec 31, 2025 | -2.08 Bn |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | -1.77 Bn |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -1.35 Bn |
| Sep 30, 2024 | -1.16 Bn |
| Jun 30, 2024 | -998.57 Mn |
| Mar 31, 2024 | -106,000.00 |
| Dec 31, 2023 | -65,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | -161.62 Mn |
| Dec 31, 2022 | 284,000.00 |